Directory
>
Mathieu Nonnenmacher
Mathieu Nonnenmacher
PhD student | Voyager Therapeutics, Inc.
Massachusetts, Cambridge, United States
Mathieu Nonnenmacher
Summary
Mathieu Nonnenmacher is a seasoned leader in the field of gene therapy, currently serving as Vice President of Capsid Discovery at Voyager Therapeutics, Inc. Based in Cambridge, Massachusetts, Mathieu has an extensive background in virology and cell biology, having held various senior roles in both academic and corporate settings. His expertise spans several critical areas, including vector engineering and therapeutic gene transfer, which are pivotal in developing innovative treatments for brain-related diseases. With a PhD from the prestigious Institut Pasteur, he has contributed significantly to research on Papillomavirus and has been instrumental in advancing gene therapy technologies. Mathieu is fluent in both French and English, enhancing his ability to collaborate in diverse environments. His career trajectory showcases a commitment to scientific excellence and a passion for translating research into impactful therapies.
Mathieu Nonnenmacher
Work Experience
Vice President - Gene Therapy at
Voyager Therapeutics, Inc.
January 2025 - Present
Frequently Asked Questions about Mathieu Nonnenmacher
What is Mathieu Nonnenmacher email address?
Mathieu Nonnenmacher's primary email address is *************@voyagertherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mathieu Nonnenmacher work for?
Mathieu Nonnenmacher is a PhD student at Voyager Therapeutics, Inc..
How can I directly contact Mathieu Nonnenmacher?
To contact Mathieu Nonnenmacher directly, you can use the email address *************@voyagertherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Mathieu Nonnenmacher?
Mathieu Nonnenmacher is a seasoned leader in the field of gene therapy, currently serving as Vice President of Capsid Discovery at Voyager Therapeutics, Inc. Based in Cambridge, Massachusetts, Mathieu has an extensive background in virology and cell biology, having held various senior roles in both academic and corporate settings. His expertise spans several critical areas, including vector engineering and therapeutic gene transfer, which are pivotal in developing innovative treatments for brain-related diseases. With a PhD from the prestigious Institut Pasteur, he has contributed significantly to research on Papillomavirus and has been instrumental in advancing gene therapy technologies. Mathieu is fluent in both French and English, enhancing his ability to collaborate in diverse environments. His career trajectory showcases a commitment to scientific excellence and a passion for translating research into impactful therapies.
Mathieu`s contact details
*************@voyagertherapeutics.com
Colleagues
chief Engineer
Account Executive
Post Doc. Researcher
Instructor in Neurology
Research Scientist
VP, Head of Information Technology
Associate Attorney in Corporate Dept.
Senior Auditor
Vice President, Vector Engineering